Volume 3, Issue 4

Chair's Welcome

Practice Edge

• ABA Roundtable on Gene Patenting

• Artificial Intelligence, Telemedicine, and Robotics in Health Care

• BioBlurb

• EDDE Journal

• SciStatus Update


• How to be a Better Lawyer?

Learn How E-Discovery is Practiced Before Federal Judges

• Library of Congress Survey (username: glins; password: survey)

SciTech Nominees for 2010-2011 Officer and Council Member Elections

Sponsorship Opportunities



Cyber on the Hill: Congressional Cybersecurity Oversight, Legislation & Initiatives for 2010
May. 10, 2010
Crowell & Moring LLP
Washington, DC
Multiple Formats

First Annual Electronic Discovery and Digital Evidence
May. 19, 2010 - May. 20, 2010
Chicago Kent College of Law (IIT)
Chicago, IL

Patent Licensing for Standards How the Deal Is Done
May 25, 2010

Prescriptions for Criminal Justice Forensics
June 5, 2010
New York, NY

Navigating the US Biosimilar Pathway
June 29, 2010
Registration: Coming Soon

Flying High with Technology: A Review of Legal, Privacy, and International Issues Behind Aviation Security Tecnology
June 29, 2010
Washington, DC
Multiple Formats
Registration: Coming Soon



 The advancement of technology in the past decade has catapulted the prominence of electronic evidenc... Read More

 This book provides you with a legal and practical approach to the new world of digital information. It has been described as a must have  for litigation lawyers, corporate counsel and records managers who want to understand how to appropriately handle the digital information of an enterprise. Read more.

The SciTech Lawyer

 The Section's quarterly magazine features practical and timely articles on a diverse range of science and technology law issues. This issue focuses on select aspects of science and policy during year one under Obama.

Contact Us

The SciTech e-Merging News is published quarterly as a Section member benefit. Click here to join the Section. The material published reflects the views of the authors and has not been approved by the Section of Science & Technology Law, the House of Delegates or the Board of Governors of the ABA. © 2010 American Bar Association. All rights reserved.

Practice Edge

BIOBLURB by Sofya Bakalova


A Message from your Editor:

Greetings, dear readers! Below please find the latest issue of the BioBlurb. As always I encourage attorneys, law students, and industry professionals to submit biotech-related stories of interest to my e-mail address. In this issue, find out why the FDA chided a major drug maker, the US Supreme Court is bracing for case load increase, and venture capitalists continue to show interest in Biotech sector!

Thank you,

Sofya Bakalova

"Scientists Track Variant of Gene-Regulating Protein in Embryonic Stem Cells."
The journey from embryonic stem cell to a fully developed liver, heart or muscle cell requires not only the right genes, but genes that are turned on and off at the right time, according to Science Daily (April 16, 2010).

Gene Variant Linked to Thinking Skills in Elderly. A gene variant that may help protect memory and thinking skills in elderly people has been identified by U.S. researchers. Discovery may lead to new treatments for age-related memory loss, according to Health Day News (April 21, 2010).

"Chinese Scientists Discover Marker Indicating the Developmental Potential of Stem Cells."Researchers in China are reporting that they have found a way to determine which differentiated body cells that have been reprogrammed into a primordial, embryonic-like state are the most viable for therapeutic applications, according to Science Daily (April 18, 2010).

Hormone Sensitivity of Breast Stem Cells Presents Drug Target . Researchers at the Walter and Eliza Hall Institute (Australia) have discovered that breast stem cells are exquisitely sensitive to the female hormones estrogen and progesterone, a finding that opens the way for the development of new preventions and treatments for breast cancer, according to Science Daily (April 12, 2010).

"First-Quarter VC Investments Up 38 Percent Over Last Year."Venture capitalists invested $1.3 billion in 160 deals in the life sciences industry during the first quarter, with $825 million going to biotech firms, according to American City Business Journals (April 16, 2010).

Price Controls Expected to Slow Drug Sales in 2010. Pharmaceutical sales growth worldwide will slow this year due to expiring patents for 'blockbuster'
drugs and tighter price controls imposed by European governments, according to Google News/ The Associated Press (April 21, 2010).

"FDA Chides Glaxo for Cancer-Drug Ad."The FDA warned GlaxoSmithKline regarding promotional material that the agency said fails to adequately state the risks of cancer drug Arzerra and bladder treatment Vesicare, according to The Wall Street Journal (April 16, 2010).

U.S. Reforms to Hurt Non-Profit Hospitals . The healthcare overhaul will ultimately hurt the credit profiles of not-for-profit hospitals, despite some positive effects, according to Reuters (April 16, 2010).

Cancer Research by U.S. Disorganized, Underfunded, Study Says . An analysis by the Institute of Medicine shows that 40% of Phase III clinical trials conducted by the Clinical Trials Cooperative Group Program, a unit of the National Cancer Institute, end up being terminated because of inefficiency and lack of funding, according to Bloomberg (April 15, 2010).

Resistance to Health Care Bill Strong . Associated Press-GfK poll finds that the number of Americans opposed to the health reform law increased after it was enacted, according to The Washington Post (April 15, 2010).

"Breyer: Health Overhaul Could Come Before Court."Supreme Court Associate Justice Stephen Breyer said he expects an increase in the high court's caseload as several states plan to challenge the constitutionality of certain provisions of the new health reform law, according to The Washington Post (April 15, 2010).

More Harm Than Good? Patenting Genes is Bad for Diagnosis . Economic rationale for single gene patenting is clear, but latest research suggests that exclusive licensing of gene-based diagnostic tests may deprive many patients of the benefits of genetic discoveries, according to The Economist (April 15, 2010).

Genetics in Medicine April 2010 Supplement:


Sofya Bakalova
University of Miami School of Law
J.D. Candidate - Class of 2010

This weekly update is a FREE member benefit of the Biotechnology Law Committee. Click here to join the Biotechnology Law Committee for FREE.


Your e-mail address will only be used within the ABA and its entities. We do not sell or rent e-mail addresses to anyone outside the ABA.

Update your profile | Unsubscribe | Privacy Policy

American Bar Association | 321 N Clark | Chicago, IL 60610 | 1-800-285-2221